Asphalion SL

Asphalion SL is an SME in Barcelona, Spain that has taken part in 29 EU-funded projects since 2013, receiving €5.9M in EU funding.

EU funding received€5.9M
EU projects29
As coordinator0
Running now14
First EU project2013
Latest project2026
CountrySpain
EU registration (PIC)951218473
On this page · 5 sections→

Where the EU money came from

Funding by EU programme. Amounts are Asphalion SL's own share of each project, not the project's full budget.

  • Horizon 2020€3.1M · 13 projects
  • Horizon Europe€2.7M · 15 projects
  • FP7 (2007 to 2013)€160k · 1 project

Projects

29 EU-funded projects, newest first. Each links to the official record.

  • DYNAMISAssociated partner

    IDIBAPS Doctoral programme Yielding Novel Advancements in Medicine and Innovative Solutions

    Horizon Europe · 2026–2030 · Project on CORDIS ↗

  • VIVIDPartner

    Clinical Validation of In Vivo Imaging for Detecting Immune Dynamics

    Horizon Europe · 2025–2028 · Project on CORDIS ↗

    €128ktheir share
  • GreenNanoBonePartner

    Sustainable 4D hydrogels functionalised with plant-based nanoparticles for bone regeneration in cancer patients

    Horizon Europe · 2025–2029 · Project on CORDIS ↗

    €197ktheir share
  • HYDROHEALPartner

    Multi-functional hydrogels for promoting bone fracture healing through local induced release of pharmaceutical agents and gradual matrix replacement by the regenerating bone

    Horizon Europe · 2025–2029 · Project on CORDIS ↗

    €196ktheir share
  • MEDiCSPartner

    Anticancer approach based on the Metabolic Disruption of Cancer Stem Cells with high effectivity across a wide range of solid tumours

    Horizon Europe · 2025–2028 · Project on CORDIS ↗

    €153ktheir share
  • KeratOPrinterPartner

    Advanced 4D Printing Technologies in Corneal Regeneration: A Pathway to Restored Vision

    Horizon Europe · 2025–2029 · Project on CORDIS ↗

    €267ktheir share
  • IMMUTOLPartner

    ADVANCED ANTIGEN-SPECIFIC DENDRITIC CELL-BASED THERAPY TO RE-ESTABLISH TOLERANCE IN IMMUNE-MEDIATED DISEASES

    Horizon Europe · 2023–2027 · Project on CORDIS ↗

    €198ktheir share
  • PragmaTILPartner

    Pragmatic approach to Adoptive Cell Therapy (ACT) using Tumor Infiltrating Lymphocytes (TIL) in selected solid tumors

    Horizon Europe · 2023–2028 · Project on CORDIS ↗

    €168ktheir share
  • FORCE REPAIRPartner

    smart and multiFunctional 3D printable prO-Regenerative biologiCal matrix modulating mEchanotRansduction as advancEd theraPy to treAt skIn chRonic wounds

    Horizon Europe · 2023–2026 · Project on CORDIS ↗

    €176ktheir share
  • NABIHEALPartner

    ANTIMICROBIAL NANOSTRUCTURED BIOMATERIALS FOR COMPLEX WOUND HEALING

    Horizon Europe · 2023–2026 · Project on CORDIS ↗

    €134ktheir share
  • METHYLOMICPartner

    DNA methylation markers to predict treatment success of biologicals in Crohn’s disease.

    Horizon Europe · 2023–2026 · Project on CORDIS ↗

    €239ktheir share
  • EChiLiBRiSTPartner

    Development and validation of a quantitative point-of-care test for the measurement of severity biomarkers to improve risk stratification of fever syndromes and enhance child survival

    Horizon Europe · 2022–2027 · Project on CORDIS ↗

    €128ktheir share
  • ETERNALPartner

    Boosting the reduction of the environmental impact of pharmaceutical products throughout their entire life cycle.

    Horizon Europe · 2022–2026 · Project on CORDIS ↗

    €152ktheir share
  • SINPAINPartner

    A game changer for the treatment of osteoarthritis: a cost effective combined advanced therapy to treat knee osteoarthritis

    Horizon Europe · 2022–2026 · Project on CORDIS ↗

    €204ktheir share
  • RBDCOVPartner

    RBD Dimer recombinant protein vaccine against SARSCoV2

    Horizon Europe · 2021–2025 · Project on CORDIS ↗

    €350ktheir share
  • UroPrintPartner

    Urinary bladder bioprinting for fully autologous transplantation

    Horizon 2020 · 2021–2025 · Project on CORDIS ↗

    €75ktheir share
  • Tumor-LN-oCPartner

    Tumor and Lymph Node on Chip for cancer studies

    Horizon 2020 · 2021–2025 · Project on CORDIS ↗

    €237ktheir share
  • SPIOMET4HEALTHPartner

    PCOS IN ADOLESCENT GIRLS AND YOUNG WOMEN: TOWARD A TREATMENT GUIDED BY PATHOPHYSIOLOGY

    Horizon 2020 · 2021–2026 · Project on CORDIS ↗

    €223ktheir share
  • IN2SIGHTPartner

    AN IN VIVO BIOENGINEERED CHIP AS A SMART INTRAVITAL MULTIPHOTON IMAGING WINDOW FOR NEW VALIDATION PROTOCOLS OF BIOMATERIALS

    Horizon 2020 · 2021–2025 · Project on CORDIS ↗

    €265ktheir share
  • VASCOVIDPartner

    PORTABLE PLATFORM FOR THE ASSESSMENT OF MICROVASCULAR HEALTH IN COVID-19 PATIENTS AT THE INTENSIVE CARE

    Horizon 2020 · 2020–2023 · Project on CORDIS ↗

    €182ktheir share
  • ARDATPartner

    Accelerating Research & Development for Advanced Therapies

    Horizon 2020 · 2020–2026 · Project on CORDIS ↗

    €353ktheir share
  • MISTRALPartner

    Microbiome-based stratification of individuals at risk of HIV-1 acquisition, chronic clinical complications,antimicrobial drug resistance,and unresponsiveness to therapeutic HIV-1 vaccination

    Horizon 2020 · 2020–2025 · Project on CORDIS ↗

    €141ktheir share
  • SBRPartner

    SMART BONE REGENERATION

    Horizon 2020 · 2020–2024 · Project on CORDIS ↗

    €318ktheir share
  • CardioReGenixPartner

    CardioReGenix: Development of Next-Generation Gene Therapies for Cardiovascular Disease

    Horizon 2020 · 2019–2024 · Project on CORDIS ↗

    €310ktheir share
  • nTRACKPartner

    Multimodal nanoparticles for structural and functional tracking of stem cell therapy on muscle regeneration

    Horizon 2020 · 2017–2022 · Project on CORDIS ↗

    €306ktheir share
  • HIVACARPartner

    Evaluating a Combination of Immune-based Therapies to Achieve a Functional Cure of HIV Infection

    Horizon 2020 · 2017–2022 · Project on CORDIS ↗

    €175ktheir share
  • MYOCUREPartner

    Development of an innovative gene therapy platform to cure rare hereditary muscle disorders

    Horizon 2020 · 2016–2019 · Project on CORDIS ↗

    €275ktheir share
  • ELASTISLETPartner

    Tailored Elastin-like Recombinamers as Advanced Systems for Cell Therapies in Diabetes Mellitus: a Synthetic Biology Approach towards a Bioeffective and Immunoisolated Biosimilar Islet/Cell Niche

    Horizon 2020 · 2015–2019 · Project on CORDIS ↗

    €223ktheir share
  • IHIVARNAPartner

    Therapeutic TriMix / mRNA based Vaccine in Chronic HIV-1 Infected Patients Receiving Antiretroviral Therapy

    FP7 (2007 to 2013) · 2013–2017 · Project on CORDIS ↗

    €160ktheir share

Works most with

Organisations that shared the most EU projects with this one. A good starting list for consortium partners.

Fields it works in

Research fields recorded on its Horizon projects.

  • DNA
  • HIV
  • antibiotic resistance
  • artificial bone
  • autoimmune diseases
  • biomaterials
  • bioreactors
  • biosensors
  • breast cancer
  • cardiology
  • cells technologies
  • coronaviruses
  • critical care medicine
  • deep learning

Asphalion SL is listed on EUACC

See the startup profile for its product, team and what it is looking for.

Open the startup profile →

Source: CORDIS (Horizon Europe, Horizon 2020, FP7) and the EU Funding & Tenders Portal (other EU programmes), matched by the EU registration number (PIC). Past participation does not mean the organisation is open to new partnerships. Official website ↗

Europe’s tech funding.
One place.

The weekly briefing

Funding calls, VC news and key deadlines — a weekly briefing for European founders.

Free · unsubscribe anytime